Dengue cases in Tamil Nadu rise, but improved awareness and protocols lead to fewer complications and deaths this year.
Updated Positive Data at ASH 2025 Reinforce the Potential of Incyte's INCA033989, its First-in-Class mutCALR-Targeted ...
Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard ...
Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard therapy went longer without a bleeding episode that needed urgent treatment or ...
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 8, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company developing CID-103, a potentially best-in-cl ...
Are you a mid high-tier normie or subhuman? Explaining the guide to attractiveness that's blowing up on TikTok.